Analysis of the Former Delaware Research and Development Tax Credit Cap

The Former Credit Cap ($5 Million Cap) was an aggregate annual statutory limit on the total dollar amount of Research and Development (R&D) tax credits that the State of Delaware could award to all eligible businesses. When the collective claims from all applicants exceeded this $5 million threshold, the Division of Revenue was required to proportionally reduce, or prorate, the approved credit amount for every firm.

This limitation was central to the Delaware R&D tax credit regime prior to 2017, imposing significant restrictions on the incentive’s utility and predictability for innovative businesses operating within the state. The statutory credit, administered under Title 30, Chapter 20, Subchapter VIII of the Delaware Code 1, has since undergone critical legislative changes that fundamentally altered its scope and economic value. The analysis that follows details the mechanics of the former cap, the statutory guidance surrounding its repeal, and the lasting compliance implications for taxpayers.

I. Executive Overview: Defining the Former Delaware R&D Credit Cap

The historical $5 million cap acted as a ceiling on the state’s financial commitment to the R&D incentive program, meaning that regardless of the volume of qualified research conducted in Delaware, the total tax benefit dispensed in a given year would not surpass this mandated dollar figure.3

The Paradigm Shift in Delaware R&D Policy

For many years, the existence of the aggregate cap created an environment of financial uncertainty for companies relying on the R&D credit. Prior to the legislative reform, the credit was not only subject to proration but was also non-refundable and limited to 50% of the tax liability otherwise due.5 This structure meant that even a potentially large, approved credit might be significantly diluted—first by the statewide cap, and then by the individual tax liability restriction—before any benefit was realized.

The presence of a fixed annual dollar cap implies a legislative approach where the incentive was primarily structured as a controlled budgetary expenditure, rather than a dynamic policy tool designed to scale directly with the volume of qualified research investment.4 By constraining the total payout, the state placed a hard limit on the potential economic impact. If R&D investment among Delaware firms increased dramatically, the cap fixed the subsidy at $5 million, causing the incentive’s effective rate (the subsidy per dollar of qualified research expenditure) to decrease. This structural limitation often undermined the stated policy goal of encouraging innovation proportional to investment, particularly when Delaware sought to position itself as a hub for high-tech economic development.

The turning point was the passage of the Commitment to Innovation Act (80 Del. Laws, c. 207), which repealed the cap and made the credit fully refundable, effective for tax periods after December 31, 2016.7 This legislative action signaled a strategic pivot, transforming the Delaware R&D credit into a highly competitive incentive designed to align more closely with high-tech growth and investment.

II. Statutory and Regulatory Foundation: The Pre-2017 Regime

The historical application of the cap requires an understanding of the specific statutory constraints codified under Title 30, Chapter 20, Subchapter VIII of the Delaware Code, specifically related to the Credit for Research (§ 2070 and related provisions).1

Legal Authority and Administration

The Delaware R&D credit is patterned after the federal credit outlined in Internal Revenue Code (IRC) Section 41. Taxpayers seeking the Delaware credit must base their calculations on Qualified Research Expenses (QREs) as defined under IRC §41.3 The state law, however, offers two distinct calculation methodologies, both of which were subject to the former cap:

1. Method A (Excess QREs): A credit calculated as 10% of the excess of current-year Delaware QREs over a statutorily defined Delaware base amount. This rate was doubled to 20% for small businesses (those with average annual gross receipts not exceeding $20 million).1
2. Method B (Apportioned Federal Credit): A credit equal to 50% of Delaware’s apportioned share of the taxpayer’s federal R&D tax credit, calculated using the alternative incremental credit method. For small businesses, this rate was 100%.1

Defining the Aggregate Cap and the Proration Mechanism

The crucial pre-2017 limitation was the mandate that the total aggregated amount of R&D credits approved by the Division of Revenue for all firms in any given calendar year could not surpass the $5 million limit.3

If the Division of Revenue determined that the sum of all approved R&D credit claims statewide exceeded $5,000,000, proration was mandatory.5 The law required that the amount of the credit for every qualifying applicant be reduced proportionally to ensure the total awards remained precisely at the $5 million ceiling.4 This reduction was applied uniformly across all approved claims, regardless of the size of the applicant or the calculation method used.

Associated Pre-2017 Restrictions: The Dual Limitation

The cap did not operate in isolation; its effect was amplified by two other constraints that severely limited the immediate value of the incentive:

1. Usage Limitation: The approved credit amount was restricted to offsetting only 50% of the taxpayer’s qualified tax liability (the tax otherwise due) for that taxable year.5
2. Non-Refundability and Carryforward: Any portion of the approved credit that was unused due to the 50% liability limitation, or that was lost through the proration mechanism, was designated as a non-refundable carryforward.4 These unused amounts could be carried forward for a maximum of 15 subsequent tax years.3

The confluence of the aggregate cap, proration, and the usage/refundability limitations introduced significant volatility and uncertainty into the financial planning process. Because the ultimate awarded credit value depended on the total collective claims submitted by competing businesses statewide, a company could not accurately forecast its effective credit rate until the Division of Revenue had finalized all statewide applications, often months after the tax year had concluded. This fundamental lack of predictability hindered corporate decisions regarding future cash flow and capital allocation, thereby diminishing the credit’s overall efficacy as a reliable incentive for R&D investment.

III. Division of Revenue Guidance and Legislative Action (The Repeal)

The repeal of the aggregate cap was driven by legislative efforts to modernize and enhance Delaware’s tax structure to better compete nationally for high-value research jobs.

The Commitment to Innovation Act (2016)

The $5 million cap was abolished as a key measure within the Commitment to Innovation Act (80 Del. Laws, c. 207). This bipartisan bill was publicly supported by Governor Markell and signed into law in March 2016.4 The primary objective of the legislation was to remove these restrictive limits, ensuring that all companies could receive the full R&D tax credit amount for which they qualified.4 The same legislation also eliminated the requirement that the credit be limited to 50% of the tax otherwise due.5

The Critical Effective Date

The elimination of the $5 million cap and the change to a fully refundable credit status became effective for tax periods beginning after December 31, 2016.6 Consequently, Tax Year 2017 marked the debut of the uncapped, modernized R&D credit regime.

Official Division of Revenue Guidance

The Delaware Division of Revenue provided formal confirmation and instruction regarding this transition. The General Instructions for the credit application forms (e.g., Form 2071AC) explicitly stated the new rules: “After January 1, 2017, there is no longer a $5,000,000 cap on total tax credits issued by the State of Delaware and the R&D Tax Credits are now refundable”.8 Taxpayers are still required to apply for approval using Delaware forms and attach their federal Form 6765, which documents the federal R&D calculation.3

Policy Transformation: The Post-2017 Landscape

The transition created a powerful new incentive framework. The two most substantial benefits of the post-2017 regime are:

1. Elimination of the Cap: All approved companies now receive 100% of their calculated credit, eliminating the need for proration.5
2. Full Refundability: If the approved credit amount exceeds the taxpayer’s tax liability, the taxpayer is entitled to receive the excess amount as a tax refund, providing an immediate cash injection.2 This benefit is particularly vital for high-growth firms and startups that may not yet be generating substantial taxable income.

The decision by Delaware’s legislature to eliminate the cap, despite projecting a significant increase in potential revenue expenditure (ultimately reaching an estimated $24 million by FY 2022, far surpassing the former $5 million ceiling 4), demonstrates a recognition that the R&D credit is a necessary, high-cost component of competing for advanced industry and mobile capital. The former cap was correctly identified as an artificial barrier to economic scaling, and its removal signified a commitment to prioritize innovation investment over immediate budget constraint.

The table below summarizes the profound policy differences between the two eras of the Delaware R&D tax credit.

Table 2: Key Differences: Delaware R&D Credit Before and After 2017 Legislation

IV. Technical Case Study: Proration Modeling Under the Former Credit Cap

To fully appreciate the financial volatility caused by the $5 million cap, it is necessary to examine how the proration mechanism was applied when statewide claims exceeded the threshold.

Methodology for Proration

The Delaware Division of Revenue used a standardized factor to determine the prorated credit amount awarded to each applicant. This Proration Factor (PF) was derived by dividing the fixed statutory cap by the total aggregate amount of all approved claims filed statewide for that tax year.

The formula for calculating the Proration Factor (PF) was:

$$PF = \frac{\text{\$5,000,000}}{\text{Total Aggregate Approved Claims}}$$

The final awarded credit for a specific taxpayer was then calculated by multiplying their initial approved credit by the calculated PF.

Example: Scenario Setup (Hypothetical Pre-2017 Tax Year)

Consider a hypothetical tax year, such as 2015, where four distinct companies submit substantial, fully approved R&D credit claims to the Delaware Division of Revenue.

• Company A’s Calculated Credit: $\$2,500,000$
• Company B’s Calculated Credit: $\$4,000,000$
• Company C’s Calculated Credit: $\$1,000,000$
• Company D’s Calculated Credit: $\$2,500,000$

The Total Aggregate Approved Claims for the tax year equal $10,000,000. Since this amount significantly exceeds the $5 million cap, proration is triggered.

Step-by-Step Calculation of the Awarded Credit

1. Determine the Proration Factor (PF):
   
   $$PF = \frac{\$5,000,000 \text{ (Statutory Cap)}}{\$10,000,000 \text{ (Total Claims)}} = 0.50 \text{ or } 50\%$$
2. Apply Proration: Since the factor is 50%, every company’s initially calculated credit is halved. The remaining 50% becomes the unused, non-refundable carryforward amount, subject to the 15-year expiration window.4

Table 1: Proration Impact of the Former $5 Million Aggregate Cap (Hypothetical Pre-2017)

This modeling demonstrates the dual constraint that severely hampered the financial utility of the credit. For example, Company B calculated a $4 million credit, but the cap immediately reduced the potential award to $\$2$ million. This $\$2$ million was then further restricted by the 50% usage limitation against the company’s current-year tax liability. If Company B had a qualified tax liability of only $\$1$ million, they could only use $\$500,000$ of the awarded credit (50% of $\$1$ million), leaving the remaining $\$1.5$ million of the awarded credit, plus the $\$2$ million lost to proration, to be carried forward as a non-refundable balance. The original calculated credit of $\$4$ million was thus reduced to an immediate usable benefit of only $\$500,000$, illustrating how the combined constraints drastically limited the immediate economic benefit of the incentive, particularly for lower-profit, high-research investment firms.

V. Policy Evolution, Utilization Statistics, and Compliance Implications

The repeal of the cap was a policy response to the structural inadequacies of the former regime, yet it introduced new administrative demands relating to the management of legacy credits.

Post-Repeal Utilization Statistics

The economic impact of eliminating the cap was immediate and substantial, demonstrating that the $\$5$ million ceiling was consistently suppressing demand for the credit. Post-repeal utilization statistics reveal the actual cost of the R&D incentive, reflecting the commitment Delaware made to innovation:

• Estimated Revenue Loss (Credit Utilization) FY 21: $\$17.5$ million.4
• Estimated Revenue Loss (Credit Utilization) FY 22: $\$24.0$ million.4

These figures confirm that, in the post-cap environment, credit utilization is nearly five times higher than the limit imposed under the former statute. This sharp increase confirms that the cap was a major barrier to the incentive’s effectiveness and that the removal of this artificial ceiling successfully increased the financial subsidy provided to businesses conducting R&D in the state.

The Bifurcated Credit Pool: Tracking Carryforwards

For corporate tax professionals, the most complex ongoing compliance challenge stemming from the historical cap is the management of the “bifurcated credit pool.” Credits generated today are fully refundable, but any unused credit originating from a capped, pre-2017 tax year retains its original, restrictive character.4

1. Legacy Credits (Pre-2017): Any carryforward balance derived from R&D activity performed in a tax year starting before January 1, 2017, remains strictly non-refundable. These credits are subject to a 15-year carryforward window, after which they expire if unused.4
2. Modern Credits (Post-2017): Credits generated in tax periods beginning after 2016 are fully refundable, offering immediate cash value if they exceed the current year’s tax liability.6

Compliance and Audit Considerations

The maintenance of two distinct pools of credit requires meticulous credit sequencing. Taxpayers must implement internal tracking systems to properly manage the application and expiration dates of each credit vintage.

Generally, taxpayers are advised to apply the oldest credits first (First-In, First-Out, or FIFO) to minimize the risk of expiration. However, the non-refundable nature of the legacy credits sometimes makes their use strategically complex. An audit review by the Delaware Division of Revenue will require documentation proving that a non-refundable, potentially prorated carryforward from a 2016 tax year, for instance, was properly utilized before any refundable credits from subsequent years were claimed as a cash refund.

This perpetual difference in treatment between legacy carryforwards (non-refundable, capped, limited use) and modern credits (refundable, uncapped, full use) significantly increases administrative complexity. This complexity, in turn, imposes an ongoing administrative burden and cost on corporate tax departments that must manage this dual system until all 15-year carryforwards from the capped era have either been successfully applied or have expired.

VI. Conclusion: Strategic Implications for Modern Delaware Businesses

The former $5 Million Credit Cap was the single most defining feature of the historical Delaware R&D tax credit program, acting as an inflexible restraint on state fiscal policy and severely limiting the financial utility of the incentive for individual firms. The mechanics of the cap—mandating proration when statewide claims exceeded the ceiling—introduced crippling uncertainty, compounded by the inability to claim any unused portion as a refund and the restriction to offsetting only 50% of the tax liability.

The legislative decision embodied in the Commitment to Innovation Act to eliminate the cap, effective for tax periods after December 31, 2016, constituted a strategic elevation of the R&D incentive. By uncaping the program and instituting full refundability, Delaware transformed its R&D credit into a predictable, robust, and immediately valuable tool for economic development, allowing credit utilization to scale in direct proportion to business investment.

While the cap itself is now history, its legacy persists in the form of non-refundable carryforward balances originating from pre-2017 tax years. Taxpayers must maintain rigorous internal controls to segregate and track these legacy credits, ensuring that they are applied strictly in accordance with the former statute’s non-refundable and expiration rules, thereby minimizing audit risk and maximizing the value of the modern, fully refundable Delaware R&D tax credit.

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/